← All Inspira Technologies Oxy Bhn LTD filings

Inspira Technologies Oxy Bhn LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
IINN
Inspira Technologies Oxy Bhn LTD
20-F: Inspira Technologies Reports 2025 Losses, Eyes Growth Amid Going Concern Doubts
Inspira Technologies, a medical device company, reported a net loss of $13.2 million for 2025, its first revenue of $289,000 from ART100 sales, and faces going concern doubts while advancing its life-support technologies.
NASDAQ
IINN
Inspira Technologies Oxy Bhn LTD
20-F/A: Inspira Technologies Files Amendment to 20-F Annual Report, Addressing Auditor Opinion Date
Inspira Technologies Oxy B.H.N. Ltd. files an amendment to its annual report on Form 20-F solely to update the date of the auditor's opinion, with no changes to the financial statements themselves.
NASDAQ
IINN
Inspira Technologies Oxy Bhn LTD
20-F: Inspira Technologies Reports Full Year 2024 Results, Highlights Regulatory Milestones and Strategic Collaborations
Inspira Technologies' 2024 annual report details progress in regulatory approvals, product development, and strategic partnerships, while also addressing financial challenges and future growth strategies.
NASDAQ
IINN
Inspira Technologies Oxy Bhn LTD
20-F: Inspira Technologies Navigates Regulatory Milestones and Expands Product Pipeline in 2023
Inspira Technologies advances its respiratory support technology, achieving key regulatory submissions and expanding its product line in 2023, while addressing financial uncertainties.